Using advanced chest X-ray technology to screen for lung cancer
Chest X-ray Tomosynthesis for Detection of Lung Cancer and Lung Disease
This study is testing a new type of chest X-ray to see if it can find lung cancer as well as or better than regular CT scans for people being screened for the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 30 Years to 85 Years |
| Sex | All |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT06577883 on ClinicalTrials.gov |
What this trial studies
This observational clinical trial aims to evaluate the effectiveness of chest tomosynthesis as a potential alternative to computed tomography (CT) for lung cancer detection. Participants will undergo both chest tomosynthesis and routine CT scans to compare their diagnostic accuracy. The study also focuses on developing artificial intelligence tools to enhance the detection of lung cancer in tomosynthesis images. Researchers will assess the sensitivity and specificity of this new imaging technique in a population undergoing lung cancer screening or evaluation of suspicious lung nodules.
Who should consider this trial
Good fit: Ideal candidates include individuals undergoing lung cancer screening, evaluation of suspicious lung nodules, or those with newly diagnosed lung cancer.
Not a fit: Patients with a prior history of lung cancer treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a less invasive and more accessible method for early lung cancer detection.
How similar studies have performed: Other studies have shown promise in using advanced imaging techniques for lung cancer detection, but this specific approach with chest tomosynthesis is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * undergoing lung cancer screening * undergoing evaluation of suspicious pulmonary nodule * newly diagnosed lung cancer Exclusion Criteria: * prior history of lung cancer treatment
Where this trial is running
San Diego, California
- University of California San Diego — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Albert Hsiao, MD PhD — UC San Diego, Department of Radiology
- Study coordinator: Alexander Cypro, MD
- Email: aidaresearch2023@gmail.com
- Phone: 858-2462196
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.